European Commission approves new treatment for severe asthma
Exdensur (depemokimab) is the first and only ultra-long-acting biologic in the EU to treat severe asthma and chronic…
TGA approves new severe asthma treatment Exdensur for Australians
A newly registered asthma treatment has been given the green light by the Therapeutic Goods of Australia (TGA),…
GSK gets FDA approval for Exdensur asthma treatment
Key Terms
eosinophilic phenotype
medical
An eosinophilic phenotype…